XML 76 R37.htm IDEA: XBRL DOCUMENT v3.20.1
Stock Compensation (Tables)
3 Months Ended
Mar. 31, 2020
Stock Compensation [Abstract]  
Schedule of Share Based Compensation Stock Options Activities

The following table summarizes stock option activity during the three months ended March 31, 2020:

Weighted

Average

Number

Weighted

Remaining

Aggregate

of Options

Average

Contractual

Intrinsic Value

    

(in thousands)

    

Exercise Price

    

Term (years)

    

(in thousands)

Outstanding at December 31, 2019

 

1,981

$

99.87

 

7.4

$

65,662

Granted

 

557

$

99.94

 

$

Exercised

 

(9)

$

47.78

 

$

Cancelled/forfeited

 

(63)

$

97.85

 

$

Expired

 

(20)

$

198.78

 

$

Outstanding at March 31, 2020

 

2,446

$

99.32

 

7.7

$

6,106

Expected to vest

 

1,256

$

92.39

 

9.0

$

1,005

Exercisable

 

1,190

$

106.62

 

6.4

$

5,101

Schedule of Share Based Compensation Arrangement By Share Based Payment Award Grants in Period Fair Value Assumptions

The Company estimated the fair value of stock options granted in the periods presented utilizing a Black-Scholes option-pricing model utilizing the following assumptions:

Three Months Ended March 31, 

    

2020

    

2019

Volatility

 

61.9 - 87.1

%

87.0 - 87.2

%

Expected term (in years)

 

6.0

 

6.0

 

Risk-free rate

 

0.9 - 1.7

%  

2.5 - 2.9

%

Expected dividend yield

 

%  

%

Schedule of Share-based Compensation, Restricted Stock Units Award Activity

The following table summarizes the aggregate RSU, restricted stock award (“RSA”), PRSU and performance restricted share award (“PRSA”) activity during the three months ended March 31, 2020:

Weighted

Number of

Average Grant Date

    

Awards

    

Fair Value

(in thousands)

Non-vested awards at December 31, 2019

 

709

$

88.39

Granted

 

399

$

102.82

Vested

(104)

$

74.75

Forfeited

 

(43)

$

94.43

Non-vested awards at March 31, 2020

 

961

$

95.58

Schedule of Stock Based Compensation Expense

Stock-based compensation expense has been reported in the Company’s condensed consolidated statements of operations as follows:

Three Months Ended March 31, 

    

2020

    

2019

(in thousands)

Selling, general and administrative

$

9,723

$

11,331

Research and development

 

2,750

 

3,566

Total stock-based compensation

$

12,473

$

14,897